An examination of pharmaceutical systems in severely disrupted countries
Open Access
- 6 December 2012
- journal article
- other
- Published by Springer Nature in BMC International Health and Human Rights
- Vol. 12 (1) , 1-11
Abstract
This research assesses informal markets that dominate pharmaceutical systems in severely disrupted countries and identifies areas for further investigation. Findings are based on recent academic papers, policy and grey literature, and field studies in Somalia, Afghanistan, the Democratic Republic of Congo and Haiti. The public sector in the studied countries is characterized in part by weak Ministries of Health and low donor coordination. Informal markets, where medicines are regularly sold in market stalls and unregulated pharmacies, often accompanied by unqualified medical advice, have proliferated. Counterfeit and sub-standard medicines trade networks have also developed. To help increase medicine availability for citizens, informal markets should be integrated into existing access to medicines initiatives.Keywords
This publication has 10 references indexed in Scilit:
- Navigating uncertainty: Observations from the Congo-Rwanda border2012
- Composition of pluralistic health systems: how much can we learn from household surveys? An exploration in CambodiaHealth Policy and Planning, 2011
- A Decade of Aid to the Health Sector in Somalia 2000-20092011
- Afghanistan Pharmaceutical Sector Development: Problems and ProspectsSouthern Med Review, 2011
- Fragile States: Securing DevelopmentSurvival, 2008
- Substandard medicines in resource‐poor settings: a problem that can no longer be ignoredTropical Medicine & International Health, 2008
- Increasing Access to Surgical Services for the Poor in Rural Haiti: Surgery as a Public Good for Public HealthWorld Journal of Surgery, 2008
- Formal and informal pharmaceutical economies in Third World countries: Synergetic, symbiotic or parasitical?Crime, Law and Social Change, 2006
- Education in the Democratic Republic of Congo2005
- The informal pharmaceuticals market in the Democratic Republic of CongoDevelopment in Practice, 1998